Clinical facial weakness and multimodal electrophysiology in amyotrophic lateral sclerosis: motor unit number index, nerve conduction, and blink reflex
- 1Department of Neurology, Central Hospital, Tianjin University/Tianjin Third Central Hospital
- 2Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases
- 3Tianjin Artificial Cell Engineering Technology Research Center
Abstract
Background: Cheek-puff weakness is clinically recognised in amyotrophic lateral sclerosis (ALS), but its relation to non-invasive facial electrophysiology is uncertain.
Objective: The primary objective was to test whether participant-level orbicularis oris motor unit number index (MUNIX) was lower in ALS than in healthy controls after age and sex adjustment. Secondary and exploratory objectives related cheek-puff weakness to facial MUNIX, nerve conduction, blink reflex, and onset phenotype.
Methods: In this retrospective cross-sectional study, we analysed 43 patients with ALS, 25 healthy controls (Control A), and 42 peripheral vestibular disease controls (Control B).
Results: The adjusted primary MUNIX difference versus Control A was not significant ( β = −7.08; p = 0.153). Cheek-puff weakness was more frequent than eye-closure weakness (21/43 versus 4/43; exact McNemar p < 0.001) and was associated with lower orbicularis oris MUNIX after age and sex adjustment ( β = −13.09; p = 0.006). In limb-onset ALS, cheek-puff weakness remained associated with lower MUNIX after additional adjustment ( β = −17.40, 95% confidence interval −30.56 to −4.25; p = 0.011); only nine patients had bulbar-onset ALS, limiting comparison between onset groups. Orbicularis oris distal motor latency remained longer after adjustment ( p = 0.011), and R2 was abnormal in 11/39 patients versus 0/42 Control B participants ( p < 0.001).
Conclusion: Assessment of cheek puff and eye closure is relevant irrespective of ALS onset site. Orbicularis oris MUNIX was associated with clinically observed cheek-puff weakness but was not supported as a stand-alone ALS marker. Distal latency and R2 provided additional, largely non-overlapping information. Prospective validation against cranial-muscle electromyography and longitudinal bulbar outcomes is required.
Related
- GDF5 as a Multimodal Protector of the Motor Unit in Amyotrophic Lateral Sclerosis
- Multivariate analysis identifies distinct latent components and highlights the contribution of motor cortex neurochemistry to clinical variance in amyotrophic lateral sclerosis
- Multimodal Effects of CD40L Blockade in Multiple Sclerosis: Insights from Preclinical and Clinical Studies
- Transcutaneous Carbon Dioxide Monitoring in Amyotrophic Lateral Sclerosis: A Scoping Review
- The value of a family history to distinguish monogenic from polygenic amyotrophic lateral sclerosis
BibTeX
@article{wang2026clinical,
title = {{Clinical facial weakness and multimodal electrophysiology in amyotrophic lateral sclerosis: motor unit number index, nerve conduction, and blink reflex}},
author = {Yu Wang and Yanping Ren and Ju Zhu and Na Liu and Li Tian},
journal = {Frontiers in Neurology},
year = {2026},
month = nov,
doi = {10.3389/fneur.2026.1982458},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1982458/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Clinical facial weakness and multimodal electrophysiology in amyotrophic lateral sclerosis: motor unit number index, nerve conduction, and blink reflex
AU - Yu Wang
AU - Yanping Ren
AU - Ju Zhu
AU - Na Liu
AU - Li Tian
PY - 2026
DA - 2026/11/16
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1982458
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1982458/full
AB - Background: Cheek-puff weakness is clinically recognised in amyotrophic lateral sclerosis (ALS), but its relation to non-invasive facial electrophysiology is uncertain. Objective: The primary objective was to test whether participant-level orbicularis oris motor unit number index (MUNIX) was lower in ALS than in healthy controls after age and sex adjustment. Secondary and exploratory objectives related cheek-puff weakness to facial MUNIX, nerve conduction, blink reflex, and onset phenotype. Methods: In this retrospective cross-sectional study, we analysed 43 patients with ALS, 25 healthy controls (Control A), and 42 peripheral vestibular disease controls (Control B). Results: The adjusted primary MUNIX difference versus Control A was not significant ( β = −7.08; p = 0.153). Cheek-puff weakness was more frequent than eye-closure weakness (21/43 versus 4/43; exact McNemar p < 0.001) and was associated with lower orbicularis oris MUNIX after age and sex adjustment ( β = −13.09; p = 0.006). In limb-onset ALS, cheek-puff weakness remained associated with lower MUNIX after additional adjustment ( β = −17.40, 95% confidence interval −30.56 to −4.25; p = 0.011); only nine patients had bulbar-onset ALS, limiting comparison between onset groups. Orbicularis oris distal motor latency remained longer after adjustment ( p = 0.011), and R2 was abnormal in 11/39 patients versus 0/42 Control B participants ( p < 0.001). Conclusion: Assessment of cheek puff and eye closure is relevant irrespective of ALS onset site. Orbicularis oris MUNIX was associated with clinically observed cheek-puff weakness but was not supported as a stand-alone ALS marker. Distal latency and R2 provided additional, largely non-overlapping information. Prospective validation against cranial-muscle electromyography and longitudinal bulbar outcomes is required.
SN - 1664-2295
ER -